Image Source: Unsplash
 

Author's Note:  Last featured 10/26/23 at $586.37.  Gained 54% since that date.

The Chart of the Day belongs to the drug manufacturer Eli Lilly (LLY). I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Seeker signaled a buy on 5/7 the stock gained 16.31%.

(Click on image to enlarge)

LLY Price vs Daily Moving Averages
 

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Barchart's Opinion Trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 20 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report.
 

Barchart Technical Indicators:

• 100% technical buy signals
• 96.22+ Weighted Alpha
• 97.15% gain in the last year
• Trend Seeker buy signal
• Above its 20, 50 and 100 day moving averages
• 15 new highs and up 12.05% in the last month
• Relative Strength Index 79.57%
• Technical support level at $894.27
• Recently traded at $904.61 with 50 day moving average of $800.37
   

Fundamental Factors:

• Market Cap $846 billion
• Revenue expected to grow 26.20% this year and increase another 23.40% next year
• Earnings estimated to increase 117.90% this year, an additional 40.00% next year and continue to compound at an annual rate of 62.63% for the next 5 years

Analysts and Investor Sentiment -- I don't buy stocks because everyone else is buying but I do realize that if major firms and investors are dumping a stock it's hard to make money swimming against the tide:

• Wall Street analysts issued 16 strong buy, 5 buy, 6 hold and 1 sell recommendation
• Analysts have price targets between $540 and $1,023 with a consensus at $905
• Value Line rates the stock its average rating of 3 with 18 month price targets between $761 and $1,485 and a mid-point of $1,123 for another 25% gain
• CFRAs MarketScope has a 5 star strong buy rating with a 12 month price target of $990
• MorningStar gives the stock a below average 1 star rating with a Fair Value of $540 about 64% over valued
• 11,780 investors monitor the stock on Seeking Alpha

More By This Author:

Chart Of The Day: McKesson - Hitting New Highs
Chart Of The Day: How Super Is American Superconductor?
Chart Of The Day: Cava Group - Mediterranean Fast Food Star